Veras Mirella, Dyer Joseph-Omer, Rooney Morgan, Barros Silva Paulo Goberlânio, Rutherford Derek, Kairy Dahlia
Health Sciences, Carleton University, Ottawa, ON, Canada.
Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal, Montréal, QC, Canada.
JMIR Res Protoc. 2023 Nov 24;12:e51873. doi: 10.2196/51873.
The integration of artificial intelligence (AI) into health sciences students' education holds significant importance. The rapid advancement of AI has opened new horizons in scientific writing and has the potential to reshape human-technology interactions. AI in education may impact critical thinking, leading to unintended consequences that need to be addressed. Understanding the implications of AI adoption in education is essential for ensuring its responsible and effective use, empowering health sciences students to navigate AI-driven technologies' evolving field with essential knowledge and skills.
This study aims to provide details on the study protocol and the methods used to investigate the usability and efficacy of ChatGPT, a large language model. The primary focus is on assessing its role as a supplementary learning tool for improving learning processes and outcomes among undergraduate health sciences students, with a specific emphasis on chronic diseases.
This single-blinded, crossover, randomized, controlled trial is part of a broader mixed methods study, and the primary emphasis of this paper is on the quantitative component of the overall research. A total of 50 students will be recruited for this study. The alternative hypothesis posits that there will be a significant difference in learning outcomes and technology usability between students using ChatGPT (group A) and those using standard web-based tools (group B) to access resources and complete assignments. Participants will be allocated to sequence AB or BA in a 1:1 ratio using computer-generated randomization. Both arms include students' participation in a writing assignment intervention, with a washout period of 21 days between interventions. The primary outcome is the measure of the technology usability and effectiveness of ChatGPT, whereas the secondary outcome is the measure of students' perceptions and experiences with ChatGPT as a learning tool. Outcome data will be collected up to 24 hours after the interventions.
This study aims to understand the potential benefits and challenges of incorporating AI as an educational tool, particularly in the context of student learning. The findings are expected to identify critical areas that need attention and help educators develop a deeper understanding of AI's impact on the educational field. By exploring the differences in the usability and efficacy between ChatGPT and conventional web-based tools, this study seeks to inform educators and students on the responsible integration of AI into academic settings, with a specific focus on health sciences education.
By exploring the usability and efficacy of ChatGPT compared with conventional web-based tools, this study seeks to inform educators and students about the responsible integration of AI into academic settings.
ClinicalTrails.gov NCT05963802; https://clinicaltrials.gov/study/NCT05963802.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/51873.
将人工智能(AI)融入健康科学专业学生的教育具有重要意义。人工智能的快速发展为科学写作开辟了新视野,并有可能重塑人机技术交互。教育中的人工智能可能会影响批判性思维,导致需要解决的意外后果。了解在教育中采用人工智能的影响对于确保其负责任和有效使用至关重要,使健康科学专业学生能够凭借必要的知识和技能在人工智能驱动技术的不断发展的领域中前行。
本研究旨在详细介绍研究方案以及用于调查大型语言模型ChatGPT的可用性和有效性的方法。主要重点是评估其作为辅助学习工具在改善本科健康科学专业学生学习过程和学习成果方面的作用,特别强调慢性病方面。
这项单盲、交叉、随机对照试验是一项更广泛的混合方法研究的一部分,本文的主要重点是整个研究的定量部分。本研究共招募50名学生。备择假设假定,使用ChatGPT的学生(A组)和使用基于网络的标准工具的学生(B组)在获取资源和完成作业时,学习成果和技术可用性将存在显著差异。参与者将使用计算机生成的随机数按1:1的比例分配到AB或BA序列。两组都包括学生参与写作作业干预,干预之间有21天的洗脱期。主要结果是ChatGPT技术可用性和有效性的衡量指标,而次要结果是学生对ChatGPT作为学习工具的看法和体验的衡量指标。干预后24小时内收集结果数据。
本研究旨在了解将人工智能作为教育工具的潜在益处和挑战,特别是在学生学习的背景下。研究结果有望确定需要关注的关键领域,并帮助教育工作者更深入地了解人工智能对教育领域的影响。通过探索ChatGPT与传统基于网络的工具在可用性和有效性方面的差异本研究旨在告知教育工作者和学生如何将人工智能负责任地融入学术环境,特别关注健康科学教育。
通过探索ChatGPT与传统基于网络的工具相比的可用性和有效性,本研究旨在告知教育工作者和学生如何将人工智能负责任地融入学术环境。
ClinicalTrails.gov NCT05963802;https://clinicaltrials.gov/study/NCT05963802。
国际注册报告识别号(IRRID):PRR1-10.2196/51873。